DIROXIMEL (has an active metabolite) | DIROXIMEL | ATC L04AX07
IMMUNOSUPPRESSANTS TREATMENT OF MULTIPLE SCLEROSIS (MS) ACTIVE METABOLITE MONOMETHYL FUMARATE (MMF) ACTIVATES NUCLEAR FACTOR (ERYTHROID-DERIVED 2)-LIKE 2 (NRF2) PATHWAY | ORAL | SOLUBILITY SLIGHTLY SOLUBLE IN WATER | | Kelch-like ECH-associated protein 1 UNIPROT Q14145 KEAP1 more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |
MONOMETHYL FUMARATE (is an active metabolite) | MONOMETHYL FUMARATE | ATC L04AX07
IMMUNOSUPPRESSANTS TREATMENT OF TREATMENT OF PATIENTS WITH RELAPSING FORMS OF MULTIPLE SCLEROSIS ACTIVATES THE NUCLEAR FACTOR (ERYTHROID-DERIVED 2)-LIKE 2 (NRF2) PATHWAY NICOTINIC ACID RECEPTOR AGONIST | ORAL | Cmax 12.9 MICROMOLAR Tmax 2.25 HOUR VD 63 LITER PPB 36 PERCENT Cl 43.6 LITER / HOUR (EQN) HT 1 HOUR | NICOTINIC ACID RECEPTOR (NIACR) PDB 8JHN (STRUCTURE OF MMF-GPR109A-G PROTEIN COMPLEX) LIGAND CODE = UR9 (link to the list of PDB complexes) Download experimental 3D coordinates of UR9 with added hydrogens | Kelch-like ECH-associated protein 1 UNIPROT Q14145 KEAP1 more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |